Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy ...

Novo Nordisk A/S’s weight-loss shot Wegovy gained expanded clearance as a heart drug in the UK, as the country’s regulators followed the US in broadening use of the blockbuster medicine.

Legal wins build on 111 lawsuits filed by Novo Nordisk across 32 states against entities unlawfully marketing and selling compounded "semaglutide" drugs, ... FDA-approved Wegovy ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in combination with Novo Nordisk's popular obesity drug Wegovy in a mid-stage ...

Novo Nordisk says oral version of Wegovy accepted for FDA review. May 02, 2025 2:50 PM ET ... Subject to FDA approval of the company's new ... marking the first late-stage trial win for the GLP-1 ...

CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Starting July 1, Caremark ...

When the FDA declared the shortage resolved for semaglutide, the main pharmaceutical ingredient in Wegovy and Ozempic, the agency gave 503B facilities until May 22 to stop making compounded versions.

Legal wins build on 111 lawsuits filed by Novo Nordisk across 32 states against entities unlawfully marketing and selling compounded "semaglutide" drugs, ... FDA-approved Wegovy ...

Separately, any patient who does not have insurance coverage for Wegovy or another GLP-1 can still buy Novo Nordisk's drug out-of-pocket for $499 at any of CVS' 9,000 pharmacies nationwide, the ...